-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Three Trademarks of Shijiazhuang Sihua Pharmaceutical Awarded “Hebei Excellent Brand”
Category:
发布时间：2021-08-06
Recently, the Hebei Provincial Trademark and Brand Association announced that three trademarks of Shijiazhuang Sihua Pharmaceutical Co., Ltd.—“Yilikang,” “Yirunwei,” and “Yibedi”—have been awarded the 3A-level “Hebei Excellent Brand” designation. This represents another encouraging achievement in the company’s implementation of its brand strategy.
According to available information, the 2021 “Hebei Excellent Brand” selection was an initiative launched by the Provincial Trademark and Brand Association to promote high-quality economic development through branding in the context of the ongoing pandemic. The trademarks and brands recognized under this program primarily belong to leading enterprises across various industries; their products and services are safe and reliable, and they consistently rank among the top performers in their respective sectors in key economic indicators such as sales revenue, tax contributions, and profits.
In recent years, Shijiazhuang Sihua Pharmaceutical has placed great emphasis on the cultivation and protection of intellectual property and its brands, firmly anchoring a brand-driven corporate development strategy. By leveraging this brand strategy, the company has promoted innovation, green practices, and high-quality growth, thereby establishing the “Shimen” trademark as its flagship brand and forging a new brand-building paradigm characterized by “one core brand supported by multiple complementary brands.” Through optimizing the industrial structure, nurturing and developing key brands, and enhancing brand value, Shijiazhuang Sihua Pharmaceutical has meticulously crafted a distinctive corporate identity that sets it apart, effectively boosting overall business performance and elevating its corporate image. To date, 14 of Shijiazhuang Sihua Pharmaceutical’s trademarks have been recognized as “Hebei Excellent Brands.”
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code